Facilities offering modern family planning services by survey years and facility types, 2014 and 2017. حسب Rajon Banik (12066099)

الموضوعات:

Factors associated with facility readiness for providing modern family planning services in 2014 and 2017. حسب Rajon Banik (12066099)

الموضوعات:

Modern family planning service readiness score by division in 2014 (A) and 2017 (B). حسب Rajon Banik (12066099)

الموضوعات:

Flowchart of the sample selection procedure from BHFS 2014 and 2017. حسب Rajon Banik (12066099)

الموضوعات:

Mean readiness score of modern family planning service by facility type in 2014 and 2017. حسب Rajon Banik (12066099)

الموضوعات:

Overall and domain-specific mean readiness score by survey years, 2014 and 2017. حسب Rajon Banik (12066099)

الموضوعات:

Percentage distribution (weighted) of surveyed facilities in 2014 and 2017. حسب Rajon Banik (12066099)

الموضوعات:

Datasets used in the study. حسب Rajon Banik (12066099)

الموضوعات:

Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

"…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P_i-induced VSMCs. …"

RcbA and RcbB co-operatively decrease motility independent of CaCl₂ concentration. حسب Shobnom Mustaree (21728815)

<i>Porphyromonas gingivalis</i> LPS pretreated by ozone ultrafine bubble water induces decreased TLR2 activation. حسب Mana Endo (22430706)

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"

Deep crypt secretory (DCS) cells are predominantly distributed in the proximal colon, with a progressive decrease towards the distal colon. حسب Daisuke Sugahara (2047696)

Image 2_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.jpeg حسب Joseph W. P. Nakoa (21796214)

Image 3_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.jpeg حسب Joseph W. P. Nakoa (21796214)

Image 1_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.jpeg حسب Joseph W. P. Nakoa (21796214)

Table 1_Sediment exposure decreases diversity in the surface mucus layer microbiome of Porites lobata at Honoliʻi, Hawaiʻi.xlsx حسب Joseph W. P. Nakoa (21796214)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. حسب Francesca Catto (21253435)

"…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …"

Supplementary Material for: Decreased Lactococcus lactis and propionic acid in feces of patients with Moyamoya disease: Possible implications of immune dysregulation حسب figshare admin karger (2628495)

"…Results: There were no significant differences in α- and b-diversities among feces from the MMD patients and controls. …"